These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9000592

  • 1. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
    Jayson GC, Gallagher JT.
    Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
    [Abstract] [Full Text] [Related]

  • 2. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor.
    Ishihara M, Tyrrell DJ, Stauber GB, Brown S, Cousens LS, Stack RJ.
    J Biol Chem; 1993 Mar 05; 268(7):4675-83. PubMed ID: 8444841
    [Abstract] [Full Text] [Related]

  • 3. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor.
    Ishihara M, Shaklee PN, Yang Z, Liang W, Wei Z, Stack RJ, Holme K.
    Glycobiology; 1994 Aug 05; 4(4):451-8. PubMed ID: 7827407
    [Abstract] [Full Text] [Related]

  • 4. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A.
    J Biol Chem; 1994 Jan 07; 269(1):114-21. PubMed ID: 8276782
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor.
    Walker A, Turnbull JE, Gallagher JT.
    J Biol Chem; 1994 Jan 14; 269(2):931-5. PubMed ID: 8288646
    [Abstract] [Full Text] [Related]

  • 8. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
    Coltrini D, Rusnati M, Zoppetti G, Oreste P, Grazioli G, Naggi A, Presta M.
    Biochem J; 1994 Oct 15; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421
    [Abstract] [Full Text] [Related]

  • 9. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
    Pye DA, Vivès RR, Hyde P, Gallagher JT.
    Glycobiology; 2000 Nov 15; 10(11):1183-92. PubMed ID: 11087710
    [Abstract] [Full Text] [Related]

  • 10. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A, Guimond S, Rapraeger AC.
    Biochemistry; 1996 Aug 27; 35(34):11131-41. PubMed ID: 8780517
    [Abstract] [Full Text] [Related]

  • 11. Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
    Habuchi H, Suzuki S, Saito T, Tamura T, Harada T, Yoshida K, Kimata K.
    Biochem J; 1992 Aug 01; 285 ( Pt 3)(Pt 3):805-13. PubMed ID: 1497618
    [Abstract] [Full Text] [Related]

  • 12. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
    Zhou FY, Kan M, Owens RT, McKeehan WL, Thompson JA, Linhardt RJ, Höök M.
    Eur J Cell Biol; 1997 May 01; 73(1):71-80. PubMed ID: 9174673
    [Abstract] [Full Text] [Related]

  • 13. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
    Nugent MA, Karnovsky MJ, Edelman ER.
    Circ Res; 1993 Dec 01; 73(6):1051-60. PubMed ID: 8222077
    [Abstract] [Full Text] [Related]

  • 14. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB, Rapraeger A.
    J Cell Biol; 1992 Aug 01; 118(3):631-9. PubMed ID: 1379245
    [Abstract] [Full Text] [Related]

  • 15. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.
    Roghani M, Moscatelli D.
    J Biol Chem; 1992 Nov 05; 267(31):22156-62. PubMed ID: 1429568
    [Abstract] [Full Text] [Related]

  • 16. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin.
    Sudhalter J, Folkman J, Svahn CM, Bergendal K, D'Amore PA.
    J Biol Chem; 1989 Apr 25; 264(12):6892-7. PubMed ID: 2708348
    [Abstract] [Full Text] [Related]

  • 17. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
    Watson JB, Getzler SB, Mosher DF.
    J Clin Invest; 1994 Jul 25; 94(1):261-8. PubMed ID: 8040268
    [Abstract] [Full Text] [Related]

  • 18. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes.
    Chintala SK, Miller RR, McDevitt CA.
    Arch Biochem Biophys; 1995 Jan 10; 316(1):227-34. PubMed ID: 7840621
    [Abstract] [Full Text] [Related]

  • 19. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.
    Gambarini AG, Miyamoto CA, Lima GA, Nader HB, Dietrich CP.
    Mol Cell Biochem; 1993 Jul 21; 124(2):121-9. PubMed ID: 7694075
    [Abstract] [Full Text] [Related]

  • 20. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I.
    J Cell Biochem; 1995 Feb 21; 57(2):173-84. PubMed ID: 7759555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.